Actively Recruiting
Baduanjin Training for Depression and Anxiety Patients
Led by Shanghai University of Traditional Chinese Medicine · Updated on 2026-04-29
120
Participants Needed
1
Research Sites
317 weeks
Total Duration
On this page
Sponsors
S
Shanghai University of Traditional Chinese Medicine
Lead Sponsor
S
Shanghai Mental Health Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
In recent years, the number of people with symptoms of depression or anxiety are on the rise. The aims of the prospective randomized study are: (1) to examine the effects of Baduanjin breathing training on reducing symptoms of depression or anxiety, and (2) to explore the correlates between improvements of depression or anxiety symptom and changes of lung functions.
CONDITIONS
Official Title
Baduanjin Training for Depression and Anxiety Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of depression or anxiety symptoms by ICD-10
- Depression score between 7 and 29 on HAMD-17 or anxiety score between 7 and 29 on HAMA-14
- Clear mind and ability to read, talk, and communicate
- Agreement to participate and signed informed consent
You will not qualify if you...
- Diagnosis of bipolar disorder, psychotic disorder, organic mental disorder, or cognitive disorder
- Alcohol abuse, substance dependence, or suicidal behavior in the past year
- Severe physical disease
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Qigong Research Institute
Shanghai, Shanghai Municipality, China, 021
Actively Recruiting
Research Team
Y
Ying Lu, Master
CONTACT
X
Xiaoting Zhao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here